| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/15/2002 | CN1349408A Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| 05/15/2002 | CN1349407A Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumponiae infections |
| 05/15/2002 | CN1349401A Method for regulating the condition of mammalian keratious tissue |
| 05/15/2002 | CN1348961A Estrogen-growth hormone release peptide conjugated with the function of resisting osteoporosis |
| 05/15/2002 | CN1348818A Leukemia treating granule capable of being used to replace chemotherapy and marrow transplantation |
| 05/15/2002 | CN1084595C Utilizations of edible oil |
| 05/14/2002 | US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388065 DNA for evaluating the progression potential of cervical lesions |
| 05/14/2002 | US6388061 Includes ruthenium tris(bipyridyl) label bonded to the nitrogen base |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388055 Mouse CC-CKR5 receptor polypeptide |
| 05/14/2002 | US6388054 Anti-cancer compounds |
| 05/14/2002 | US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents |
| 05/14/2002 | US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators |
| 05/14/2002 | US6388047 Hydrophobic, hydrophilic macromolecules |
| 05/14/2002 | US6387950 4((4-chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro -naphathalene-2-carbonyl)-amino)-2,6-difluoro-benzoic acid or its esters or salts used as agonists of alpha-retinoid receptors (=raralpha) |
| 05/14/2002 | US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | US6387884 Modulate binding of leukocyte to endothelial cells; antiinflammatory agents |
| 05/14/2002 | US6387882 Vision defects; oxidation resistance; cosmetics; water solubility |
| 05/14/2002 | US6387879 Compounds that bind growth to hormone receptor |
| 05/14/2002 | US6387878 Methods of treating intestinal ischemia using heparin-binding epidermal growth factor |
| 05/14/2002 | US6387877 Removal lipopolysaccharides from glycoproteins; antiinflammatory agents |
| 05/14/2002 | US6387875 Method of use for murine leukaemia inhibitory factor-binding protein (mLBP) |
| 05/14/2002 | US6387699 Antisense inhibition of A20 expression |
| 05/14/2002 | US6387696 Human calcium channel compositions and methods |
| 05/14/2002 | US6387686 Detecting nucleotide sequences which code cell surface protease; incubate target cells with viral display packages and detect signal from transformed cells |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387673 Anticarcinogenic agent composed of ligand for steroid/thyroid hormone superfamily of receptors, histone deacetylase inhibitor which interacts with receptor, and pharmaceutically acceptable carrier |
| 05/14/2002 | US6387664 Fusion protein of defined amino acid sequence and which inhibits neuron adhesion to plastic; includes secreted protein acidic and rich in cysteine; treatment of nervous system disorders |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387661 Nucleic acid molecules encoding human aminoacylase proteins |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387645 Methods and materials relating to novel CD39-like polypeptides |
| 05/14/2002 | US6387638 Heregulin variants |
| 05/14/2002 | US6387619 Telomerase compositions and methods |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387613 Human short-chain dehydrogenase |
| 05/14/2002 | US6387406 Copolymer compositions for oral delivery |
| 05/14/2002 | US6387397 Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387390 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387374 Complex consists essentially of a heat shock protein noncovalently bound to an antigenic molecule |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387370 Reducing oxysterol buildup in the blood and normalizing cholesterol and blood pressure; phytochemicals with antioxidant properties found in fruits and vegetables, including polyphenols |
| 05/14/2002 | US6387367 Human mesenchymal stem cells |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | US6387365 Alpha interferon and ribavirin where the amount of alpha interferon is less than 3 million iu weekly, qod or daily; alpha interferon is interferon alpha2; reduction of side effects |
| 05/14/2002 | US6387364 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/14/2002 | CA2249666C Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 05/14/2002 | CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 05/14/2002 | CA2234235C Gel formulations containing growth factors |
| 05/14/2002 | CA2205771C Improved delivery of disease modifiers |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2118757C Aza cyclohexapeptide compounds |
| 05/14/2002 | CA2105067C Indan derivative and thromboxane antagonist containing the same |
| 05/14/2002 | CA2104678C Protein-induced morphogenesis |
| 05/14/2002 | CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2065409C Anticoagulant polypeptides |
| 05/14/2002 | CA2032499C Polypeptide derivatives |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036816A2 Method of determining susceptibility to diseases |
| 05/10/2002 | WO2002036810A2 Antisense modulation of talin expression |
| 05/10/2002 | WO2002036809A2 Antisense modulation of sr-cyp expression |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036798A2 Inhibitors of transglutaminases |
| 05/10/2002 | WO2002036783A2 Regulation of human histone deacetylase |
| 05/10/2002 | WO2002036781A2 Regulation of human glutathione-s-transferase |
| 05/10/2002 | WO2002036774A2 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists |
| 05/10/2002 | WO2002036772A1 Novel disease-associated gene and use thereof |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036768A1 Cell division autoantigen (cda) polypeptides, gene sequences and uses thereof |
| 05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | WO2002036765A1 Novel protein and dna thereof |
| 05/10/2002 | WO2002036763A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036753A2 Human triacylglycerol lipase |
| 05/10/2002 | WO2002036743A2 Antisense modulation of calreticulin expression |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036740A2 Apoptosis-inducing ribozymes |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036731A2 Human lysosomal acid lipase |
| 05/10/2002 | WO2002036635A2 Monoclonal antibodies for assaying lipid transfer proteins |
| 05/10/2002 | WO2002036634A2 Gene regulation therapy involving ferritin |
| 05/10/2002 | WO2002036630A2 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof |
| 05/10/2002 | WO2002036628A2 New multimeric interferon beta polypeptides |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036626A1 Single-chain multimeric polypeptides |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036624A2 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 05/10/2002 | WO2002036619A1 A new polypeptide-human glycoprotein 42 and the polynucleotide encoding it |
| 05/10/2002 | WO2002036616A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036615A2 Methods for producing and improving therapeutic potency of binding polypeptides |
| 05/10/2002 | WO2002036614A2 Peptides for use in the treatment of alzheimer's disease |
| 05/10/2002 | WO2002036613A2 Regulation of human patched-like protein |
| 05/10/2002 | WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |